Neumous
PrivateLast Round
Series A
Jul 1, 2025
Total Funding Raised
$13.71M
Company Overview
Neumous operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series A round in July 2025.
Neumous is a medical device company that develops non-invasive therapeutic ultrasound technology to open the blood-brain barrier, enabling the delivery of drugs to treat brain diseases such as tumors and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neumous Comparables
Compare Neumous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delsona Therapeutics | 87% | |
| Cordance Medical | 83% | |
| Deepson Bio | 81% |
For institutional investors. Book with your work email.
Neumous Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2025 | ||||
| Grant | Apr 1, 2024 | ||||
| Grant | Jun 1, 2023 | ||||
| Grant | Apr 1, 2023 | ||||
| Seed | Apr 1, 2023 |
For institutional investors. Book with your work email.
Neumous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| SL Investment | Series A |
| Korea Innovative Medicines Consortium | Series A |
| FuturePlay | Series A |
| Chungbuk Center for Creative Economy & Innovation | Seed |
| IBK Venture Investment | Series A |
| Ministry of Health and Welfare (South Korea) | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
$7M round led by SL Investment.
- Apr 1, 2024
$1.2M grant from Ministry of Health and Welfare (South Korea)
For institutional investors. Book with your work email.
Neumous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neumous's valuation, stock price, and market status.
Is Neumous a public or private company?
Neumous is a private company.
What is the current stock price of Neumous?
Neumous is a private company, so its shares have no public market price. Caplight tracks Neumous's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neumous worth (valuation)?
Valuation information for Neumous is not publicly available.
Can I buy Neumous stock?
Neumous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neumous's last funding round?
Neumous's most recent funding round was Series A on July 1, 2025.
Who are the main investors in Neumous?
Key investors in Neumous include SL Investment.
Will Neumous IPO soon?
No public IPO plans have been announced for Neumous.
How can I track Neumous secondary market activity?
Caplight tracks bids, offers, and trades in Neumous's shares on secondary markets.